Consensus on Women's Health Aspects of Polycystic Ovary Syndrome: The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

    December 2011 in “ Fertility and sterility
    Bart C.J.M. Fauser, Basil C. Tarlatzis, Robert W. Rebar, Richard S. Legro, Adam Balen, Roger A. Lobo, Enrico Carmina, Jae Chun Chang, Bülent Okan Yıldız, Joop S.E. Laven, Jacky Boivin, Felice Petraglia, C. N. Wijeyeratne, Robert J. Norman, Andrea Dunaif, Stephen Franks, Robert A. Wild, Daniel A. Dumesic, Kurt T. Barnhart
    Image of study
    TLDR Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.
    The third PCOS consensus workshop group, which met in Amsterdam in October 2010, focused on women's health issues related to polycystic ovary syndrome (PCOS). The group acknowledged the lack of consensus on diagnosing PCOS in adolescents, given that irregular menses are common after menarche. Hirsutism was recognized as a reliable indicator of hyperandrogenism, but no effective treatment for alopecia was identified. The efficacy of treatments for hirsutism, including oral contraceptive pills and antiandrogens, remains unclear. The workshop also noted that menstrual irregularities are prevalent in PCOS, but the rate of spontaneous ovulation is unknown. The document further discussed the benefits of oral contraceptives for PCOS patients, the increased risk of psychological disorders, and the heightened risk of adverse pregnancy outcomes in women with PCOS. It was found that menstrual irregularities correlate with increased metabolic risk and PCOS severity. Metformin was reported to have no benefit for fertility or live-birth rates in anovulatory PCOS. Additionally, the document highlighted ethnic variations in PCOS expression and the need for further research on the natural history of menstrual irregularity, long-term outcomes for children of PCOS patients, and the impact of specific diets around conception.
    Discuss this study in the Community →

    Research cited in this study

    29 / 29 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 month ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  57 upvotes 10 months ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community C’est terrible - at my wits end

      in Female  448 upvotes 10 months ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 3 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    6 / 1000+ results